Abeona secures cash runway with $155m priority review voucher sale
Abeona’s deal value is in line with recent voucher sale transactions amid uncertain times in rare disease drug development.
Abeona’s deal value is in line with recent voucher sale transactions amid uncertain times in rare disease drug development.
What's Your Reaction?
